{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:42:19Z","timestamp":1770478939127,"version":"3.49.0"},"reference-count":27,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sao Paulo Med. J."],"published-print":{"date-parts":[[2003]]},"abstract":"<jats:p>CONTEXT: This study makes a comparison between two subtypes of panic disorder regarding the clinical efficacy of clonazepam, a benzodiazepine. OBJECTIVES: To evaluate the clinical efficacy of clonazepam in a fixed dosage (2 mg\/day), compared to placebo, in the treatment of panic disorder patients and to verify whether there are any differences in the responses to clonazepam between panic disorder patients with the respiratory and non-respiratory subtypes. TYPE OF STUDY: Randomized study with clonazepam and placebo. SETTING: Outpatient Anxiety and Depression Unit of the Institute of Psychiatry, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. PARTICIPANTS: 34 patients with a diagnosis of panic disorder with agoraphobia, between 18 and 55 years old. PROCEDURES: Administration of clonazepam or placebo for 6 weeks, in panic disorder patients, after they were classified within two subtypes of panic disorder: respiratory and non-respiratory. MAIN MEASUREMENTS: Changes in the number of panic attacks in comparison with the period before the beginning of the study; Hamilton Anxiety Scale; Global Clinical Impression Scale; and Patient's Global Impression scale. RESULTS: In the group that received clonazepam, by the end of the 6th week there was a statistically significant clinical improvement, shown by the remission of panic attacks (p &lt; 0.001) and decrease in anxiety (p = 0.024). In the group that received clonazepam there was no significant difference between the respiratory and non-respiratory subtypes of panic disorder, regarding the therapeutic response to clonazepam. CONCLUSION: Clonazepam was equally effective in the treatment of the respiratory and non-respiratory subtypes of panic disorder, suggesting there is no difference in the therapeutic response between the two subtypes.<\/jats:p>","DOI":"10.1590\/s1516-31802003000200009","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T14:53:41Z","timestamp":1114613621000},"page":"77-80","source":"Crossref","is-referenced-by-count":16,"title":["Therapeutic response to benzodiazepine in panic disorder subtypes"],"prefix":"10.1590","volume":"121","author":[{"given":"Alexandre Martins","family":"Valen\u00e7a","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio de Janeiro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Egidio","family":"Nardi","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Andr\u00e9","family":"Mezzasalma","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter Ara\u00fajo","family":"Zin","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana Le\u00e3o","family":"Lopes","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio","family":"Versiani","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"16","key":"ref1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/archpsyc.1967.01730190120016","article-title":"Importance of psychiatric diagnosis in prediction of clinical drug effects","volume":"1","author":"Klein DF","year":"1967","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.2000.tb10947.x","article-title":"Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors","volume":"403","author":"Zohar J","year":"2000","journal-title":"Acta Psychiatr Scand","ISSN":"https:\/\/id.crossref.org\/issn\/0001-690X","issn-type":"print"},{"issue":"6","key":"ref3","first-page":"301","article-title":"O tratamento da doen\u00e7a do p\u00e2nico: 1\u00aa aula","volume":"38","author":"Versiani M","year":"1989","journal-title":"J Bras Psiquiatr","ISSN":"https:\/\/id.crossref.org\/issn\/0047-2085","issn-type":"print"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1176\/ajp.141.1.149b","article-title":"Antipanic effect of clonazepam: letter","volume":"141","author":"Fontaine R","year":"1984","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archpsyc.1988.01800290027004","article-title":"Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment","volume":"45","author":"Ballenger JC","year":"1988","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00464571","article-title":"Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study","volume":"77","author":"Chouinard G","year":"1982","journal-title":"Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3158","issn-type":"print"},{"issue":"2","key":"ref7","first-page":"83","article-title":"Clonazepam in the treatment of patients with recurrent panic attacks","volume":"47","author":"Beaudry P","year":"1986","journal-title":"J Clin Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"key":"ref8","first-page":"12","article-title":"Clonazepam: a review of open clinical trials","volume":"48","author":"Pollack MH","year":"1987","journal-title":"J Clin Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"key":"ref9","series-title":"Handbook of Psychiatric Drug Therapy","author":"Hyman SE","year":"1995"},{"key":"ref10","first-page":"16","article-title":"Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial","volume":"48","author":"Tesar GE","year":"1987","journal-title":"J Clin Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"key":"ref11","first-page":"14","article-title":"Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects","volume":"51","author":"Svebak S","year":"1990","journal-title":"J Clin Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1192\/bjp.163.2.201","article-title":"Subtyping of panic disorder by symptom profile","volume":"163","author":"Briggs AC","year":"1993","journal-title":"Br J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1250","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1192\/bjp.157.4.593","article-title":"Symptom specificity in patients with panic","volume":"157","author":"Lelliott P","year":"1990","journal-title":"Br J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1250","issn-type":"print"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1522-7154(1996)2:2<99::AID-ANXI7>3.0.CO;2-8","article-title":"Cardio-respiratory and other symptom clusters in panic disorder","volume":"2","author":"Bandelow B","year":"1996","journal-title":"Anxiety","ISSN":"https:\/\/id.crossref.org\/issn\/1070-9797","issn-type":"print"},{"key":"ref15","series-title":"Structured Clinical Interview Diagnostic (SCID) for DSM-IV axis I Disorder-Clinician Version (SCID-CV)","author":"First MB","year":"1997"},{"key":"ref16","series-title":"Diagnostic and Statistical Manual for Mental Disorders DSM-IV","year":"1994","edition":"4"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/070674379103600413","article-title":"Low doses of clonazepam in the treatment of panic disorder","volume":"36","author":"Pols H","year":"1991","journal-title":"Can J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0706-7437","issn-type":"print"},{"issue":"2","key":"ref18","first-page":"169","article-title":"Pivotal studies of clonazepam in panic disorder","volume":"34","author":"Davidson JR","year":"1998","journal-title":"Psychopharmacol Bull","ISSN":"https:\/\/id.crossref.org\/issn\/0048-5764","issn-type":"print"},{"issue":"2","key":"ref19","first-page":"69","article-title":"Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder","volume":"52","author":"Tesar GE","year":"1991","journal-title":"J Clin Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"key":"ref20","first-page":"4","article-title":"High-potency benzodiazepines for short-term management of panic disorder: the U. S. experience","volume":"51","author":"Tesar GE","year":"1990","journal-title":"J Clin Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004714-199404000-00005","article-title":"Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response","volume":"14","author":"Beauclair L","year":"1994","journal-title":"J Clin Psychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0271-0749","issn-type":"print"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5694\/j.1326-5377.1986.tb113758.x","article-title":"Clonazepam in the treatment of panic disorder","volume":"145","author":"Judd FK","year":"1986","journal-title":"Med J Aust","ISSN":"https:\/\/id.crossref.org\/issn\/0025-729X","issn-type":"print"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00004714-199710000-00008","article-title":"Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group","volume":"17","author":"Rosenbaum JF","year":"1997","journal-title":"J Clin Psychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0271-0749","issn-type":"print"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4088\/JCP.v60n0907","article-title":"Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages","volume":"60","author":"Moroz G","year":"1999","journal-title":"J Clin Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1590\/S1516-44462001000100005","article-title":"Ataques de p\u00e2nico provocados pelo di\u00f3xido de carbono: estudo cl\u00ednico-fenomenol\u00f3gico","volume":"23","author":"Valen\u00e7a AM","year":"2001","journal-title":"Rev Bras Psiquiatr"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1176\/ajp.156.5.739","article-title":"Panic disorder subtypes: differential responses to CO2 challenge","volume":"156","author":"Biber B","year":"1999","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004714-199606000-00007","article-title":"Phenomenology of panic attacks: responsiveness of individual symptoms to imipramine","volume":"16","author":"Mavissakalian MR","year":"1996","journal-title":"J Clin Psychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0271-0749","issn-type":"print"}],"container-title":["Sao Paulo Medical Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/spmj\/v121n2\/a09v1212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T01:56:20Z","timestamp":1683078980000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-31802003000200009&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003]]}},"alternative-id":["S1516-31802003000200009"],"URL":"https:\/\/doi.org\/10.1590\/s1516-31802003000200009","relation":{},"ISSN":["1516-3180"],"issn-type":[{"value":"1516-3180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003]]}}}